Quick Answer
Cytek Biosciences, Inc. reported Total Assets of $461.54 million for fiscal year 2025.
Cytek Biosciences, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $461.54M | -7.6% |
| 2024 | $499.50M | +1.0% |
| 2023 | $494.46M | -4.8% |
| 2022 | $519.48M | +12.1% |
| 2021 | $463.31M | +110.6% |
| 2020 | $219.98M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $494.92M | +0.8% | +0.3% |
| June 30, 2025 | $493.32M | +2.0% | +2.2% |
| March 31, 2025 | $482.60M | -1.9% | -3.4% |
| December 31, 2024 | $499.50M | +1.0% | +1.7% |
| September 30, 2024 | $491.23M | -5.4% | +1.6% |
| June 30, 2024 | $483.73M | -7.9% | -1.7% |
| March 31, 2024 | $492.07M | -6.2% | -0.5% |
| December 31, 2023 | $494.46M | -4.8% | -4.8% |
- Cytek Biosciences, Inc. showed a decrease of -7.6% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Cytek Biosciences, Inc.’s total assets has grown by 109.8% (from $219.98 million to $461.54 million).
- The most recent figure is from Cytek Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: